CoChat

Rationally designed capsid and transgene cassette of AAV6 vectors for dendritic cell‐based cancer immunotherapy

Pandya, Jheel, Ortiz, Luis, Ling, Chen, Rivers, Angela E, Aslanidi, George · 2014 · Immunology & Cell Biology
Cited by 55

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Dendritic cell (DC)‐based immunotherapy has recently demonstrated a great potential for clinical applications; however, additional progress in the methods of tumor‐specific antigen delivery to DCs is necessary for the further development of anti‐tumor vaccines. To this end, a capsid‐optimized adeno‐associated virus serotype 6 (AAV6‐T492V+S663V) vector was developed by site‐directed mutagenesis of surface‐exposed serine (S) and threonine (T) residues, which have a critical role in intracellular trafficking of AAV vectors. This double‐mutant AAV6 vector had ∼5‐fold greater transduction efficiency in monocyte‐derived DCs (moDCs) compared with wild‐type (WT)‐AAV6 vectors. The increase in the transduction efficiency correlated with the improved nuclear translocation of AAV6‐T492V+S663V over that of the WT‐AAV6 vector. Additional studies of the CD11c promoter identified critical regulatory elements that fit into the AAV expression cassette and drive EGFP expression in moDCs. Development of a chimeric promoter (chmCD11c) that contains functional modules of CD11c and a Simian virus (SV40) enhancer element dramatically increased the EGFP expression in moDCs. MoDCs transduced by the capsid‐optimized AAV6 vector carrying human prostate‐specific antigen (hPSA) driven by CBA (AAV6‐T492V+S663V‐CBA‐hPSA) or chmCd11c (AAV6‐T492V+S663V‐chmCD11c‐hPSA) generated specific T‐cell clone proliferation and superior cytotoxic T lymphocytes (CTLs) with higher killing capability against human prostate adenocarcinoma cells, LNCaP, compared with WT‐AAV6 induced CTLs. Taken together, these studies suggest that optimization of capsid and promoter components of AAV vectors can be a useful approach for efficient targeting of moDCs and may prove to be a promising tool for cancer immunotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/icb.2013.74

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

Metadata

Authors
Pandya, J., Ortiz, L., Ling, C., Rivers, A. E., & Aslanidi, G.
Venue
Immunology & Cell Biology
Publisher
Wiley
Published
2013-11-12
Volume
92
Issue
2
Pages
116-123
ISSN
  • 0004-945X (ISSN-L)
  • 0818-9641
  • 1440-1711
OpenAlex
W1988235678
Cited by
55
References
9
FWCI
3.03
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.